Osvaren (Magnesium Carbonate Heavy, Calcium Acetate)

Magnesium carbonate heavy, the active ingredient in Osvaren, is a mineral supplement presented as a solid oral dosage for gastrointestinal use. It helps to correct low magnesium levels and supports normal muscle and nerve function in adults. GNH USA supplies Osvaren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Osvaren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Osvaren is used to address mineral deficiencies that affect the body's electrolyte balance.

- Hypomagnesemia: Restores normal magnesium concentrations in patients with low serum magnesium. - Metabolic acidosis: Assists in neutralising excess acidity in the bloodstream. - Renal stone prevention: Provides magnesium that can bind calcium, reducing stone formation.

Adverse reactions to Osvaren are generally mild and related to its mineral nature.

Common Side Effects: - Diarrhoea: Loose stools may occur, especially with higher doses. - Abdominal discomfort: Cramping or bloating can be reported. - Nausea: A feeling of queasiness may develop after ingestion. - Flatulence: Increased gas production is possible. - Constipation: Some patients may experience reduced bowel movements.

Serious or Rare Side Effects: - Hypermagnesemia: Excessive magnesium levels can cause muscle weakness, low blood pressure, and cardiac arrhythmias. - Severe allergic reaction: Rash, itching, swelling, or difficulty breathing may indicate anaphylaxis. - Electrolyte imbalance: Marked shifts in calcium or potassium levels may occur. - Renal impairment exacerbation: Accumulation of magnesium in patients with reduced kidney function. - Metabolic acidosis worsening: Rarely, magnesium carbonate may affect acid‑base status.

When using Osvaren, consider the following safety measures:

- Assess renal function: Impaired kidneys reduce magnesium clearance and increase toxicity risk. - Monitor serum electrolytes: Regular checks help detect hypermagnesemia or related imbalances. - Adjust dose in the elderly: Age‑related renal decline may require lower dosing. - Avoid concurrent laxatives: Combined use can amplify gastrointestinal side effects. - Review concomitant medications: Certain drugs (e.g., bisphosphonates) may interact with magnesium. - Store at ambient temperature: Keep below 25°C in the original container, protected from moisture.

Osvaren may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Bisphosphonates: Magnesium can impair oral absorption of bisphosphonates, reducing their effectiveness. - Tetracycline antibiotics: Co‑administration lowers tetracycline absorption, risking treatment failure. - Potassium‑sparing diuretics: Combined use may precipitate hypermagnesemia.

Moderate Interactions (Monitor Closely): - Calcium supplements: High calcium intake can compete with magnesium absorption. - Cardiac glycosides: Magnesium may potentiate effects on cardiac conduction. - Proton pump inhibitors: Altered gastric pH can affect magnesium dissolution and uptake.